PARAMETRIC PORTFOLIO ASSOCIATES LLC - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 86 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2022$295,000
-66.3%
31,731
-42.8%
0.00%
Q4 2021$875,000
+3.2%
55,496
+17.2%
0.00%
Q3 2021$848,000
-6.0%
47,351
-18.4%
0.00%
-100.0%
Q2 2021$902,000
-3.2%
58,027
-10.6%
0.00%0.0%
Q1 2021$932,000
-4.5%
64,894
+30.6%
0.00%0.0%
Q4 2020$976,000
+72.1%
49,697
+13.6%
0.00%
Q3 2020$567,000
+4.8%
43,741
+17.7%
0.00%
Q2 2020$541,000
+96.7%
37,159
+15.0%
0.00%
Q1 2020$275,000
-50.9%
32,316
-4.9%
0.00%
Q4 2019$560,000
+47.4%
33,997
+26.5%
0.00%
Q3 2019$380,000
-0.5%
26,877
+179.8%
0.00%
Q1 2019$382,000
-59.6%
9,607
-64.7%
0.00%
-100.0%
Q4 2018$945,000
-17.8%
27,213
-2.1%
0.00%0.0%
Q3 2018$1,149,000
+12.4%
27,783
-0.0%
0.00%0.0%
Q2 2018$1,022,000
-3.4%
27,796
+2.4%
0.00%0.0%
Q1 2018$1,058,000
+36.5%
27,137
-36.6%
0.00%0.0%
Q4 2017$775,000
+51.4%
42,808
+38.4%
0.00%0.0%
Q3 2017$512,000
+23.4%
30,941
+4.3%
0.00%
Q2 2017$415,000
-20.5%
29,673
+16.9%
0.00%
-100.0%
Q1 2017$522,000
+135.1%
25,389
+62.6%
0.00%
Q4 2016$222,000
-41.7%
15,615
-12.4%
0.00%
-100.0%
Q3 2016$381,000
+7.6%
17,826
+13.4%
0.00%0.0%
Q2 2016$354,00015,7200.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
KPCB XV Associates, LLC 1,876,650$29,182,00013.03%
Copernicus Capital Management, LLC 50,000$778,00012.27%
Antipodean Advisors LLC 1,000,000$15,550,0004.28%
BRIDGER MANAGEMENT, LLC 1,325,188$20,607,0001.92%
Redmile Group, LLC 6,449,577$100,291,0001.48%
MAVERICK CAPITAL LTD 7,704,676$119,808,0001.12%
Baupost Group 8,477,488$131,825,0001.07%
ACT CAPITAL MANAGEMENT, LLC 116,900$1,818,0000.93%
Trellus Management Company, LLC 73,056$1,136,0000.78%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$8,164,0000.75%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders